Efficacy and safety of s.c. infliximab in patients switched from i.v. formulation of infliximab

Conditions:   Inflammatory Bowel Diseases;   Rheumatologic Disease Intervention:   Drug: CT-P13 Sponsor:   IRCCS San Raffaele Recruiting

Source: ClinicalTrials.gov - February 9, 2023 Category: Research Source Type: clinical trials